Enis Aboalhasan
Enis Aboalhasan publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer and Pancreatic function and diabetes.
- World rank
- #4,544,682 of 7,710,434 ranked researchers
- Rank in Israel
- #27,709 of 38,292
- Works
- 33
- Citations
- 140
- Citations per work
- 4.2
What does Enis Aboalhasan research?
Enis Aboalhasan's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2678.7%
- Medicine2678.7%
- Life Sciences411.8%
- Everything else39.5%
- 1Endocrinology, Diabetes and Metabolism39% of their works
- 2Cardiology and Cardiovascular Medicine18% of their works
- 3Surgery15% of their works
- 4Molecular Biology12% of their works
- 5Oncology4% of their works
- 6Pharmacology4% of their works
Research topics
- Diabetes Treatment and Management
- Metabolism, Diabetes, and Cancer
- Pancreatic function and diabetes
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Antiplatelet Therapy and Cardiovascular Diseases
Which keywords describe Enis Aboalhasan's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Heart Failure, Cardiovascular Outcomes, Type 2 Diabetes, Diabetes Mellitus, AMP-Activated Protein Kinase and Cardiovascular Disease.
- Clopidogrel
- Aspirin
- Diagnosis
- Hyperglycemia
- Critical Care
- Pancreatic Islets
- Cardiovascular Disease
- Diabetes Mellitus
- Cardiovascular Outcomes
- Insulin Therapy
- Glycemic Control
- Heart Failure
- Type 2 Diabetes
- AMP-Activated Protein Kinase
- Metformin
- ß-Cell Dysfunction
- Diabetes
- Hypoglycemia
- Guidelines
- Chamber Quantification
- Echocardiography
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Glycemic Control333 topics
- Insulin Therapy333 topics
- Heart Failure303 topics
- Cardiovascular Outcomes231 topic
- Type 2 Diabetes231 topic
- Diabetes Mellitus132 topics
- AMP-Activated Protein Kinase91 topic
- Cardiovascular Disease92 topics
- Metformin91 topic
- Pancreatic Islets81 topic
- ß-Cell Dysfunction81 topic
- Critical Care51 topic
- Diabetes51 topic
- Hyperglycemia51 topic
- Hypoglycemia51 topic
- Diagnosis41 topic
- Guidelines41 topic
- Aspirin31 topic
- Chamber Quantification31 topic
- Clopidogrel31 topic
- Echocardiography31 topic
Where does Enis Aboalhasan work?
Enis Aboalhasan's main affiliation in the publication record is Sapir College, Israel.
How many publications and citations does Enis Aboalhasan have?
OpenAlex counts 33 works and 140 citations for Enis Aboalhasan, an h-index of 6, ranking #4,544,682 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Enis Aboalhasan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.